ELLEN JORDAN: Open Payments
NPI 1710389051 · CAMBRIDGE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,703 in 72 payments from 16 companies in 2025. Trend: 2023 $2,176 · 2024 $2,179 · 2025 $1,703
Food & beverage: $1,691Education: $12
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $350 |
| GENZYME CORPORATION | 8 | $239 |
| Janssen Biotech, Inc. | 4 | $221 |
| Novartis Pharmaceuticals Corporation | 9 | $215 |
| Regeneron Healthcare Solutions, Inc. | 5 | $163 |
| PFIZER INC. | 4 | $86 |
| Lilly USA, LLC | 4 | $86 |
| UCB, Inc. | 3 | $81 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $71 |
| Amgen Inc. | 3 | $55 |
Products named: DUPIXENT, SKYRIZI, TREMFYA, COSENTYX, RINVOQ, CIBINQO, Bimzelx, Rhapsido.
Industry payments across MD — which companies pay providers there.
